patients entered a single-blind placebo period , and if hives of moderate severity were present for at least 3 days during the week , they were randomly assigned in a double-blind fashion to take terfenadine , 60 mg twice daily , chlorpheniramine , 4 mg three times a day , or placebo for 6 weeks .
C0042109
hives
C0008281
chlorpheniramine